AMPH

Amphastar Pharmaceuticals Inc.

Price

$25.11

return (12m)

-6.15%

p/e

13.95

p/bv

1.43

DIVIDEND YIELD

0.00%

AMPH price

Amphastar Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AMPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

8.09%

3 months

28.55%

1 year

-6.15%

2 years

-45.80%

5 years

31.44%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals AMPH

Valuation

P/E

13.95

Sector 1.27

Industry 8.57

P/BV

1.43

Sector 1.88

Industry 3.63

P/Revenue (PSR)

1.50

Sector 1.56

Industry 3.09

EV/EBITDA

22.95

Sector -46.85

Industry -17.98

EV/EBIT

31.31

Sector -51.35

Industry -94.21

P/EBITDA

5.68

Sector -31.66

Industry 7.07

P/EBIT

8.55

Sector -43.19

Industry -32.11

P/Total Assets

0.63

Sector 0.87

Industry 1.32

P/Net Current Assets

-3.18

Sector -26.04

Industry -3.44

P/Working Capital

2.98

Sector -4.00

Industry 7.65

EPS

1.80

Sector -0.70

Industry -0.23

BVPS

17.60

Sector 4.48

Industry 8.61

Efficiency

Gross Margin

47.68%

Sector 49.44%

Industry 55.16%

EBITDA Margin

33.53%

Sector -282.02%

Industry -13.47%

EBIT Margin

24.58%

Sector -164.03%

Industry -25.89%

Operating Margin

15.66%

Sector -19.60%

Industry -5.67%

Net Profit Margins

10.76%

Sector -23.82%

Industry -7.67%

Asset Turnover

0.11

Sector 0.13

Industry 0.13

Profitability

ROE

10.23%

Sector -23.80%

Industry -24.00%

ROA

4.50%

Sector -24.22%

Industry -5.96%

ROIC

10.41%

Sector -587.47%

Industry -21.90%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.40

Sector 1.90

Industry 2.56

Net Debt / EBITDA

5.18

Sector -23.34

Industry 9.41

Net Debt / EBIT

7.07

Sector -11.26

Industry -2.82

Net Debt / Equity

0.42

Sector -0.63

Industry -0.19

Gross Debt / Equity

0.79

Sector -0.73

Industry 0.42

Equity/Assets

0.44

Sector 0.46

Industry 0.50

Liabilities/Assets

0.56

Sector 0.50

Industry 0.53

Growth

5Y Revenue CAGR

10.77%

Sector -

Industry -

5Y Earnings CAGR

4.81%

Sector -

Industry -

Fundamentals AMPH

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Amphastar Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$25.11

Fair Value

$26.70

Upside

6.35%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AMPH Amphastar Pharmaceuticals Inc.	$25.11	-6.98%	0.00%	13.95	1.43	10.23%	10.76%
LLY Eli Lilly and Compay	$1,139.27	38.90%	0.59%	38.06	30.01	78.84%	33.53%
SNY Sanofi	$39.70	-17.07%	4.45%	3.72	0.69	18.43%	14.25%
GSK GlaxoSmithKline PLC	$46.95	7.91%	3.77%	14.44	4.08	28.24%	14.54%
CRMD CorMedix Inc.	$7.23	-34.62%	0.00%	3.03	1.23	40.62%	40.49%
RDY Dr. Reddy's Laboratories Ltd.	$12.16	-13.79%	0.69%	27.58	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.40	-97.41%	0.00%	0.01	0.00	63.85%	0.00%
JNJ Johnson & Johnson	$255.81	40.61%	2.06%	29.27	7.25	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$395.40	-9.73%	0.00%	44.62	7.65	17.15%	28.44%
NVS Novartis AG	$140.03	8.37%	2.22%	20.91	6.36	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$652.02	23.39%	0.28%	34.69	4.59	13.22%	15.04%
ABT Abbott Laboratories	$96.56	-25.26%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$86.94	-4.56%	3.30%	21.10	2.17	10.29%	13.93%
CVS CVS Health Corporation	$86.67	17.21%	3.09%	22.49	1.38	6.12%	1.18%
BSX Boston Scientific Corp.	$42.80	-55.35%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$77.58	-32.47%	0.00%	17.68	5.18	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$520.16	-16.12%	0.00%	36.04	25.47	70.67%	25.03%
RMD ResMed Inc.	$220.18	-17.85%	1.12%	20.92	4.84	23.13%	26.94%
HCA HCA Healthcare Inc.	$428.58	1.07%	0.71%	13.82	-29.45	-213.15%	8.77%
COHR Coherent Inc.	$336.58	193.57%	0.00%	81.57	5.84	7.16%	11.31%
DHR Danaher Corporation	$214.26	2.81%	0.67%	37.74	2.87	7.61%	15.95%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AMPH - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Amphastar Pharmaceuticals

Amphastar Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (3 people)

United States

30 years

Founded: 1996

2014

Time since IPO - 12 years

1.976

Employees

Amphastar Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.10 billion, with shareholders equity totaling $768.16 million.

The company employs approximately 1.976 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Amphastar Pharmaceuticals Inc. reported $730.02 million in revenue, generating net income of $78.55 million.

Key financial metrics include a P/E ratio of 13.95, a price-to-book (P/B) ratio of 1.43, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AMPH.

Market cap

$1.10 billion

Net worth

$768.16 million

$768,157,000.00

Assets

$1.74 billion

$1,743,766,000.00

Total Shares Outstanding

43.64 million

43,644,000

Average Daily Trading Volume

$476.94 Thousand

$476,938.24

Sector

Health

Industry

Pharmaceutical Products

AMPH

AMPH revenue and profits

Financial Results AMPH

DRAG THE FRAME TO SEE MORE DATA

AMPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.67 15,38% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$267.68 --11,99% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$62.50 61,49% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$383.17 37,00% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.70 --18,93% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$255.81 38,68% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,139.27 36,51% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$428.58 0,25% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45